Showing 3071-3080 of 7509 results for "".
Beware the Redheaded Patient: Fact or Fiction in Cosmetic and Surgical Dermatology?
https://practicaldermatology.com/topics/general-topics/beware-the-redheaded-patient-fact-or-fiction-in-cosmetic-and-surgical-dermatology/21417/One of the winning presentations given by dermatology residents at the Cosmetic Surgery Forum in December 2013.Physician Spotlight: Vishal Anil Patel, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vishal-anil-patel-md/23899/How Health Care Worker Dissatisfaction is Fueling a New Trend in Health Care
https://practicaldermatology.com/topics/practice-management/how-health-care-worker-dissatisfaction-is-fueling-a-new-trend-in-health-care/23837/Despite strain, many health care workers are finding new opportunities.Stoking the Embers: Re-exploring Topical Coal Products
https://practicaldermatology.com/columns/clinical-focus-1/stoking-the-embers-re-exploring-topical-coal-products/23825/Frax Pro and CoolSculpting Elite Launch, Antibiotic Resistance in Rosacea, Thriving in Aesthetics Rolls Out
https://practicaldermatology.com/series/dermwire-tv/frax-pro-and-coolsculpting-elite-launch-antibiotic-resistance-in-rosacea-thriving-in-aesthetics-rolls-out/19896/The majority of rosacea patients have never heard of antibiotic resistance, a new survey reported by the National Rosacea Society finds. Candela’s Frax Pro system is now available, featuring Frax 1550 and the novel Frax 1940 applicators. Allergan Aesthetics, an AbbVie company, is launching CoolSculpDiagnosing and Managing Acne in Pre-Adolescent and Adolescent Patients
https://practicaldermatology.com/issues/supplements/diagnosing-and-managing-acne-in-pre-adolescent-and-adolescent-patients/23418/How to overcome challenges to effective care.DermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age aEmollient-Based Therapy for AD: A Potential Role for Rebalancing the Microbiome
https://practicaldermatology.com/issues/supplements/emollient-based-therapy-for-ad-a-potential-role-for-rebalancing-the-microbiome/23136/Exploring the Connection Between Gut Health and Hair
https://practicaldermatology.com/topics/general-topics/exploring-the-connection-between-gut-health-and-hair-1/23110/Protect or Defend: Sorting Through Oral Supplement Claims
https://practicaldermatology.com/topics/skin-cancer-photoprotection/protect-or-defend-sorting-through-oral-supplement-claims/20470/A recent FDA action calls attention to unfounded claims, but it may create some confusion.